Browse Guides  internal medicine  cardiology

Tachyarrhythmias

Clinical features
Investigations
Therapy
Prevention
Prognosis
Prevention

Paroxysmal supraventricular tachycardia
  • sotalol 80 mg or 160 mg bd po a

Why?

  • It reduces recurrent episodes of SVT a

Paroxysmal SVT: sotalol reduces recurrent episodes

Patient Treatment Comparison Outcome CER RRR
(95% CI)
NNT
(95% CI)
paroxysmal SVT or AF a sotalol placebo recurrent episode
at 1-4 weeks
89% 38%
(22% to 51%)
3
(2 to 5)

Expiry date: July 2004
Levels of Evidence used in grading these guides

Author   CM   Ball
Reviewer   H   Oral
CAT Writers   CM   Ball , N   Shenker , CJ   Wotton